A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation

Cancer Letters

Volumn 361, Issue 1, 2015, Pages 121-127

  Xue, Gang ^a,b   Ren, Zhenxin ^a   Chen, Yaxiong ^a   Zhu, Jiayun ^a   Du, Yarong ^a   Pan, Dong ^a,b   Li, Xiaoman ^a,b   Hu, Burong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

DNMT3b; Feedback loop; MiR 145; Prostate cancer; Radiosensitivity

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MICRORNA 145; 3' UNTRANSLATED REGION; DNA (CYTOSINE 5) METHYLTRANSFERASE; MESSENGER RNA; MICRORNA; MIRN145 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RADIOTHERAPY; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPIGENETICS; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; TREATMENT RESPONSE; UPREGULATION; X RAY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MICRONUCLEUS TEST; PATHOLOGY; PROSTATIC NEOPLASMS; RADIATION RESPONSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BLOTTING, WESTERN; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRONUCLEUS TESTS; MICRORNAS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; X-RAYS;

EID: 84925273591     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.046     Document Type: Article

References (44)

1. Lichtenstein A.V., Kisseljova N.P. DNA methylation and carcinogenesis. Biochemistry (Moscow) 2001, 66:235-255.
2. Yang L.H., Han Y., Li G., Xu H.T., Jiang G.Y., Miao Y., et al. Axin gene methylation status correlates with radiosensitivity of lung cancer cells. BMC Cancer 2013, 13.
3. Jiang W., Li Y.Q., Liu N., Sun Y., He Q.M., Jiang N., et al. 5-azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylation. PLoS ONE 2014, 9.
4. Daniel F.I., Cherubini K., Yurgel L.S., de Figueiredo M.A., Salum F.G. The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 2011, 117:677-687.
5. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet 2000, 9:2395-2402.
6. Kim H.J., Kim J.H., Chie E.K., Young P.D., Kim I.A., Kim I.H. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiat. Oncol 2012, 7:39.
7. Antwih D.A., Gabbara K.M., Lancaster W.D., Ruden D.M., Zielske S.P. Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics 2013, 8:839-848.
8. Kumar A., Rai P.S., Upadhya R., Vishwanatha, Prasada K.S., Rao B.S., et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. Int. J. Radiat. Biol 2011, 87:1086-1096.
9. Chen M.F., Lu M.S., Lin P.Y., Chen P.T., Chen W.C., Lee K.D. The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma. Cancer 2012, 118:4074-4089.
10. Saito Y., Kanai Y., Sakamoto M., Saito H., Ishii H., Hirohashi S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:10060-10065.
11. Gravina G.L., Ranieri G., Muzi P., Marampon F., Mancini A., Di Pasquale B., et al. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Oncol. Rep 2013, 29:1189-1195.
12. Du Y.F., Liang L., Shi Y., Long Q.Z., Zeng J., Wang X.Y., et al. Multi-target siRNA based on DNMT3A/B homologous conserved region influences cell cycle and apoptosis of human prostate cancer cell line TSU-PR1. Genet. Mol. Biol 2012, 35:164-171.
13. Yaqinuddin A., Qureshi S.A., Qazi R., Abbas F. Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration. Cancer Cell Int 2008, 8:13.
14. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
15. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol 2007, 8:23-36.
16. Petrocca F., Lieberman J. Micromanipulating cancer: microRNA-based therapeutics?. RNA Biol 2009, 6:335-340.
17. Kim K., Lee H.C., Park J.L., Kim M., Kim S.Y., Noh S.M., et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011, 6:740-751.
18. Guessous F., Zhang Y., Kofman A., Catania A., Li Y.Q., Schiff D., et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010, 9:1031-1036.
19. Wang B., Li D., Kovalchuk A., Litvinov D., Kovalchuk O. Ionizing radiation-inducible miR-27b suppresses leukemia proliferation via targeting cyclin A2. Int. J. Radiat. Oncol. Biol. Phys 2014, 90:53-62.
20. Rahman M., Lovat F., Romano G., Calore F., Acunzo M., Bell E.H., et al. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung. J. Biol. Chem 2014, 289:26406-26416.
21. Hu W., Xu S., Yao B., Hong M., Wu X., Pei H., et al. MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode. RNA Biol 2014, 11.
22. Ichimi T., Enokida H., Okuno Y., Kunimoto R., Chiyomaru T., Kawamoto K., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 2009, 125:345-352.
23. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
24. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67:6130-6135.
25. Wang S.H., Bian C.J., Yang Z., Bo Y., Li J., Zeng L.F., et al. miR-145 inhibits breast cancer cell growth through RTKN. Int. J. Oncol 2009, 34:1461-1466.
26. Sachdeva M., Zhu S.M., Wu F.T., Wu H.L., Walia V., Kumar S., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3207-3212.
27. Lu R.J., Ji Z.L., Li X.Q., Zhai Q.N., Zhao C.J., Jiang Z.M., et al. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J. Cancer Res. Clin. Oncol 2014, 140:387-397.
28. Hart M., Wach S., Nolte E., Szczyrba J., Menon R., Taubert H., et al. The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer. FEBS J. 2013, 280:2105-2116.
29. Fuse M., Nohata N., Kojima S., Sakamoto S., Chiyomaru T., Kawakami K., et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int. J. Oncol 2011, 38:1093-1101.
30. Ji W., Yang L., Yuan J., Zhang M., Qi D., Duan X., et al. MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism. Carcinogenesis 2013, 34:446-453.
31. Hanoun N., Delpu Y., Suriawinata A.A., Bournet B., Bureau C., Selves J., et al. The silencing of MicroRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem 2010, 56:1107-1118.
32. Suh S.O., Chen Y., Zaman M.S., Hirata H., Yamamura S., Shahryari V., et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 2011, 32:772-778.
33. Chin S.P., Dickinson J.L., Holloway A.F. Epigenetic regulation of prostate cancer. Clin. Epigenetics 2011, 2:151-169.
34. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
35. Vasilatou D., Papageorgiou S.G., Dimitriadis G., Pappa V. Epigenetic alterations and microRNAs new players in the pathogenesis of myelodysplastic syndromes. Epigenetics 2013, 8:561-570.
36. Boufraqech M., Zhang L., Jain M., Patel D., Ellis R., Xiong Y., et al. miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. Endocr. Relat. Cancer 2014, 21:517-531.
37. Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010, 70:378-387.
38. Chen Z., Zeng H., Guo Y., Liu P., Pan H., Deng A., et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J. Exp. Clin. Cancer Res 2010, 29:151.
39. Beaulieu N., Morin S., Chute I.C., Robert M.F., Nguyen H., MacLeod A.R. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem 2002, 277:28176-28181.
40. Liu H., Zhou Y., Boggs S.E., Belinsky S.A., Liu J. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Oncogene 2007, 26:5900-5910.
41. Palakurthy R.K., Wajapeyee N., Santra M.K., Gazin C., Lin L., Gobeil S., et al. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol. Cell 2009, 36:219-230.
42. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15805-15810.
43. Tang H.L., Deng M., Tang Y.Y., Xie X.H., Guo J.L., Kong Y.A., et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin. Cancer Res 2013, 19:5602-5612.
44. Gatto S., Della Ragione F., Cimmino A., Strazzullo M., Fabbri M., Mutarelli M., et al. Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome. Epigenetics 2010, 5:427-443.